Journals / Annals of Medical Research / 2020 / Cilt: 27 - Sayı: 10

Clinical management of tinnitus

Pages
2807–2812
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

No statistically significant difference was found between pre - and post treatment scores of the THI in lidocaine group.Conclusion: In present study, it was demonstrated that magnesium treatment is effective on tinnitus cases with acoustic trauma and misoprostol is effective on normal hearing tinnitus group, whereas intravenous lidocaine treatment was not found to be effective in tinnitus.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Tinnitus is defined as the perception of sound or sounds without any external audible source.
📊
Key Findings & Data:Therefore, we aimed to evaluate the efficacy of magnesium, misoprostol and lidocaine treatments in patients with tinnitus.Material and Methods: The 58 tinnitus cases, were evaluated retrospectively.
💡
Conclusion & Impact:No statistically significant difference was found between pre - and post treatment scores of the THI in lidocaine group.Conclusion: In present study, it was demonstrated that magnesium treatment is effective on tinnitus cases with acoustic trauma and misoprostol is effective on normal hearing tinnitus group, whereas intravenous lidocaine treatment was not found to be effective in tinnitus.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: Tinnitus is defined as the perception of sound or sounds without any external audible source. Unknown ethiopathological mechanisms with lack of standardized protocol in symptom evaluation, causes difficulties in clinical management. Therefore, we aimed to evaluate the efficacy of magnesium, misoprostol and lidocaine treatments in patients with tinnitus.Material and Methods: The 58 tinnitus cases, were evaluated retrospectively. A total number of 40 patients who were able to comply with the scheduled therapy were received two staged therapy. As first line therapy, 20 patients with sensorineural hearing loss and acoustic trauma history were received oral magnesium, while remaining 20 cases without hearing loss were received oral misoprostol. Tinnitus handicap inventory (THI) was applied to all patients before and one month after the therapy. As second line therapy, 1.5mg/kg intravenous lidocaine was administered to the patients who had ineffective treatment results according to the THI.Results: The 40 patients included in this study were 10 female (25%), and 30 male (75%) and the mean age of all patients was 41,47 years. In both magnesium and misoprostol group, the mean scores of post-treatment THI were significantly lower than pre-treatment THI scores (p-values=0,001 and 0,007, respectively). No statistically significant difference was found between pre - and post treatment scores of the THI in lidocaine group.Conclusion: In present study, it was demonstrated that magnesium treatment is effective on tinnitus cases with acoustic trauma and misoprostol is effective on normal hearing tinnitus group, whereas intravenous lidocaine treatment was not found to be effective in tinnitus.

🔖

Cite This Article

ÇOBANOĞLU, H. B., TİMURKAYNAK, Y., İMAMOĞLU, M. (2022). Clinical management of tinnitus. Annals of Medical Research, Cilt: 27 - Sayı: 10, 2807–2812. https://ajindex.com/articles/446380

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Zarenoe R, Bohn Erik PT, An T, et al. Multidisciplinary group information for patients with tinnitus: an open trial. Hearing, Balance and Communication 2018;19:1-6
  2. Hu J, Xu J, Streelman M, et al. The Correlation of the Tinnitus Handicap Inventory with Depression and Anxiety in Veterans with Tinnitus. Int J Otolaryngol.2015;2015:689375
  3. Bogo R, Farah A, Karl PT, et al.Prevalence, incidence proportion, and heritability for tinnitus: a longitudinal twin study. Ear Hear 2017;38:292-300
  4. Pawełczyk M, Rajkowska E, Kotyło P, Dudarewicz A, Camp G, Śliwińska-Kowalska M. Analysis of inner ear potassium recycling genes as potential factors associated with tinnitus. Int J Occup Med Environ Health 2012;25:356-64
  5. Tunkel DE, Bauer CA, Sun GH, et al. Clinical practice guideline: tinnitus. Otolaryngol Head Neck Surg. 2014;151:1-40
  6. Li T, Liu J, Li L, et al. Observation of Lidocainesuppressed Decrease of Magnesium in Salicylateinduced Tinnitus with an Online Electrochemical System. Electroanalysis 2018;30:1011-6
  7. Martz E, Jelleberg C, Dougherty DD, et al. Tinnitus, Depression, Anxiety, and Suicide: A Retrospective Analysis. Arch Phys Med Rehabil 2016;97:19
  8. Watts EJ, Fackrell K, Smith S, et al. Why Is Tinnitus a Problem? A Qualitative Analysis of Problems Reported by Tinnitus Patients. Trends Hear 2018;22:2331216518812250
  9. Jastreboff PJ. 25 years of tinnitus retraining therapy. HNO 2015;63:307-11
  10. Zenner HP, Delb W, Kröner-Herwig B, et al. A multidisciplinary systematic review of the treatment for chronic idiopathic tinnitus. Eur Arch Otorhinolaryngol 2017;274:2079-91
  11. Swain SK, Nayak S, Ravan JR, Sahu MC. Tinnitus and its current treatment–Still an enigma in medicine. J Formosan Med 2016;115:139-44
  12. Elgoyhen AB, Langguth B, De Ridder D, et al. Tinnitus: perspectives from human neuroimaging. Nat Rev Neurosci 2015;16:632
  13. Newman CW, Jacobson GP, Spitzer JB. Development of the Tinnitus Handicap Inventory. Arch Otolaryngol Head Neck Surg 1996;122:143-8
  14. Aksoy S, Firat Y, Alpar R. The Tinnitus Handicap Inventory: a study of validity and reliability. Int Tinnitus J 2007;13:94
  15. Langguth B, Elgoyhen AB, Cederroth CR. Therapeutic Approaches to the Treatment of Tinnitus. nnu Rev Pharmacol Toxicol 2018;25:3-23
  16. Bhatt JM, Lin HW, Bhattacharyya N. Prevalence, severity, exposures, and treatment patterns of tinnitus in the United States. JAMA Otolaryngology–Head & Neck Surgery 2016;142:959-65
  17. Axel PT, An A, Ringdahl A. Tinnitu